A Safer and Effective Approach
Recent studies have highlighted the potential of postbiotics in colorectal cancer (CRC) management. Unlike probiotics, postbiotics consist of inactivated microorganisms and their beneficial components, offering a safer alternative due to fewer concerns about production and storage. Key postbiotic components include bacterial fragments, metabolites like short-chain fatty acids (SCFAs), and enzymes. These compounds help regulate gut microbiota, strengthen the intestinal barrier, and modulate immune responses, all contributing to improved CRC outcomes. With higher safety, longer shelf life, and quicker action, postbiotics represent a promising therapeutic option for CRC.
Hi, this is a comment.
To get started with moderating, editing, and deleting comments, please visit the Comments screen in the dashboard.